226 related articles for article (PubMed ID: 30904756)
1. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold.
Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC
Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
3. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV
Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154
[TBL] [Abstract][Full Text] [Related]
5. Identification of dehydroxy isoquine and isotebuquine as promising antileishmanial agents.
Romero AH; Rodríguez N; López SE; Oviedo H
Arch Pharm (Weinheim); 2019 May; 352(5):e1800281. PubMed ID: 30994941
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
[TBL] [Abstract][Full Text] [Related]
7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of quinoline derivatives as potential cysteine protease inhibitors.
Andrade MM; Martins LC; Marques GV; Silva CA; Faria G; Caldas S; Dos Santos JS; Leclercq SY; Maltarollo VG; Ferreira RS; Oliveira RB
Future Med Chem; 2020 Apr; 12(7):571-581. PubMed ID: 32116030
[No Abstract] [Full Text] [Related]
9. 4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania.
Manzano JI; Konstantinović J; Scaccabarozzi D; Perea A; Pavić A; Cavicchini L; Basilico N; Gamarro F; Šolaja BA
Eur J Med Chem; 2019 Oct; 180():28-40. PubMed ID: 31299585
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of chalcone derivatives as antileishmanial agents.
de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Thiochroman-4-One Derivatives as Potential Leishmanicidal Agents.
Vargas E; Echeverri F; Vélez ID; Robledo SM; Quiñones W
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186046
[TBL] [Abstract][Full Text] [Related]
12. Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action.
Coimbra ES; Antinarelli LM; Silva NP; Souza IO; Meinel RS; Rocha MN; Soares RP; da Silva AD
Chem Biol Interact; 2016 Dec; 260():50-57. PubMed ID: 27789199
[TBL] [Abstract][Full Text] [Related]
13. Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin.
Silva T; Abengózar MÁ; Fernández-Reyes M; Andreu D; Nazmi K; Bolscher JG; Bastos M; Rivas L
Amino Acids; 2012 Dec; 43(6):2265-77. PubMed ID: 22543751
[TBL] [Abstract][Full Text] [Related]
14. Novel 3,4-methylenedioxyde-6-X-benzaldehyde-thiosemicarbazones: Synthesis and antileishmanial effects against Leishmania amazonensis.
de Melos JL; Torres-Santos EC; Faiões Vdos S; Del Cistia Cde N; Sant'Anna CM; Rodrigues-Santos CE; Echevarria A
Eur J Med Chem; 2015 Oct; 103():409-17. PubMed ID: 26375353
[TBL] [Abstract][Full Text] [Related]
15. Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani.
Arsène S; Gómez-Pérez V; Escarcena R; Abengózar MÁ; García-Hernández R; Nácher-Vázquez M; San Feliciano A; Gamarro F; Rivas L; Olmo ED
Eur J Med Chem; 2019 Nov; 182():111568. PubMed ID: 31419778
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids.
Baréa P; Barbosa VA; Bidóia DL; de Paula JC; Stefanello TF; da Costa WF; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2018 Apr; 150():579-590. PubMed ID: 29549842
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives.
McNulty J; Vemula R; Bordón C; Yolken R; Jones-Brando L
Org Biomol Chem; 2014 Jan; 12(2):255-60. PubMed ID: 24276426
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
